These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 27402272

  • 1. Effect of glucocorticoid withdrawal on glucocorticoid inducing bone impairment.
    Shen G, Ren H, Qiu T, Liang D, Wei Q, Tang J, Zhang Z, Yao Z, Zhao W, Jiang X.
    Biochem Biophys Res Commun; 2016 Sep 02; 477(4):1059-1064. PubMed ID: 27402272
    [Abstract] [Full Text] [Related]

  • 2. Effects of combined ovariectomy with dexamethasone on rat lumbar vertebrae.
    Ren H, Liang D, Shen G, Yao Z, Jiang X, Tang J, Cui J, Lin S.
    Menopause; 2016 Apr 02; 23(4):441-50. PubMed ID: 26694734
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [PHASIC CHANGES OF BONE MASS, BONE TURNOVER MARKERS, AND ESTROGEN LEVELS AT DIFFERENT TIME POINTS AFTER GLUCOCORTICOID INTERVENTION AND THEIR CORRELATION IN RATS].
    Ren H, Shen G, Jiang X, Liang D, Tang J, Cui J, Lin S, Zhuang H, Yang Z, Zhang S, Yao Z.
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2015 Mar 02; 29(3):307-14. PubMed ID: 26455196
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Preventive effects of berberine on glucocorticoid-induced osteoporosis in rats.
    Xu D, Yang W, Zhou C, Liu Y, Xu B.
    Planta Med; 2010 Nov 02; 76(16):1809-13. PubMed ID: 20577944
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength.
    Yao W, Dai W, Jiang L, Lay EY, Zhong Z, Ritchie RO, Li X, Ke H, Lane NE.
    Osteoporos Int; 2016 Jan 02; 27(1):283-294. PubMed ID: 26384674
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Loss of vertebral bone and mechanical strength in estrogen-deficient rats is prevented by long-term administration of zoledronic acid.
    Glatt M, Pataki A, Evans GP, Hornby SB, Green JR.
    Osteoporos Int; 2004 Sep 02; 15(9):707-15. PubMed ID: 15024556
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.
    Boutsen Y, Jamart J, Esselinckx W, Devogelaer JP.
    J Bone Miner Res; 2001 Jan 02; 16(1):104-12. PubMed ID: 11149473
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Yeast-incorporated gallium attenuates glucocorticoid-induced bone loss in rats by inhibition of bone resorption.
    Ren Z, Yang L, Xue F, Meng Q, Wang K, Wu X, Ji C, Jiang T, Liu D, Zhou L, Zhang J, Fu Q.
    Biol Trace Elem Res; 2013 Jun 02; 152(3):396-402. PubMed ID: 23532566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.